Your browser doesn't support javascript.
loading
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction.
Shibata, Takashi; Ebata, Tomoki; Fujita, Ken-ichi; Shimokata, Tomoya; Maeda, Osamu; Mitsuma, Ayako; Sasaki, Yasutsuna; Nagino, Masato; Ando, Yuichi.
Afiliación
  • Shibata T; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Ebata T; Department of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fujita K; Institute of Molecular Oncology, Showa University, Tokyo, Japan.
  • Shimokata T; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Maeda O; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Mitsuma A; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Sasaki Y; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Nagino M; Department of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ando Y; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
Cancer Sci ; 107(2): 168-72, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26595259

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias del Sistema Biliar / Desoxicitidina / Hígado / Antimetabolitos Antineoplásicos Tipo de estudio: Etiology_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias del Sistema Biliar / Desoxicitidina / Hígado / Antimetabolitos Antineoplásicos Tipo de estudio: Etiology_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2016 Tipo del documento: Article País de afiliación: Japón